Injury and illness in mountain bicycle stage racing: experience from the Trans-Sylvania Mountain Bike Epic Race.

OBJECTIVE: The popularity of mountain bicycle (MTB) riding has increased significantly since its inception in the 1970s, as have injuries from MTB riding. As MTB stage racing is a relatively new segment of MTB racing, the purpose of this study was to evaluate the injury and illness patterns associated with MTB stage racing to assist future medical providers in covering events. METHODS: The Trans-Sylvania Mountain Bike Epic Race consisted of 7 stages. An onsite medical team of physicians, nurses, and paramedics provided medical coverage. The providers logged each medical encounter on a medical form. The log included the location where the treatment was provided (on course, at the finish or after the race), a description of the injury/illness, treatment that was rendered, the supplies needed for treatment, and the disposition of the patient (continue, withdraw but continue the next day, withdraw, or transfer to the hospital). RESULTS: A total of 52 athletes competed in the inaugural edition of the race. There were 30 separate medical encounters, with a total of 34 injuries/illnesses. Of these, 22 (65%) were classified as injury, and 12 (35%) were classified as illness. Four athletes withdrew from the race, 1 from injury and 3 from illness. Skin and soft tissue injuries/illnesses were the most prevalent. CONCLUSIONS: Injury and illness patterns of MTB stage racing are similar to those of other wilderness sporting events and prior data on MTB-related injuries. Minor skin, soft tissue, and orthopedic injuries are the most common. Illness accounts for the majority of withdrawals.

Obesity hinders ultrasound visualization of the subclavian vein: implications for central venous access.

PURPOSE: International policy statements from the US and the UK recommend real-time ultrasound guidance (USG) for placement of central venous catheters (CVCs) to improve patient safety. The evidence to support USG for the internal jugular (IJ) route is unequivocal; however, there is conflicting data on the effectiveness of USG in visualization of the subclavian vein (SCV). This study sought to determine whether body mass index (BMI) or clavicle shape affected SCV visualization with USG. METHODS: Forty-one emergency department patients were enrolled. Subject height and weight were recorded for BMI calculation. The clavicle shape was recorded as either flat or protuberant. USG was performed to identify the SCV vein in both the transverse and sagittal views. The ability to visualize the vein was rated on a three point rubric scale. RESULTS: One subject had an underweight BMI, 18 a normal BMI, 12 an overweight BMI, and 10 an obese BMI. The improvement in the odds ratio (OR) of the ability to see the SCV in subjects with a normal compared to overweight/obese BMI was statistically significant (transverse view unadjusted OR=18.0 (95% CI 3.21-100.94), P=.001 and adjusted for a flat clavicle OR=10.54 (95% CI 1.41-78.37), P=.021). CONCLUSIONS: Higher BMI and the presence of a flat clavicle limit the ability to visualize the SCV. These findings may help account for why USG for placement of SCV CVCs is less utilized. However, patients with a low/normal BMI and protuberant clavicle may benefit from USG when attempting SCV CVCs.